Search details
1.
Mesothelioma: Pleural, Version 1.2024.
J Natl Compr Canc Netw
; 22(2): 72-81, 2024 03.
Article
in English
| MEDLINE | ID: mdl-38503043
2.
Non-Small Cell Lung Cancer, Version 4.2024.
J Natl Compr Canc Netw
; 22(4): 249-274, 2024 05.
Article
in English
| MEDLINE | ID: mdl-38754467
3.
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer.
Oncologist
; 28(7): 644-e564, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37186063
4.
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.
J Natl Compr Canc Netw
; 21(4): 340-350, 2023 04.
Article
in English
| MEDLINE | ID: mdl-37015337
5.
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(9): 961-979, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37673108
6.
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(5): 497-530, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35545176
7.
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic.
BMC Cancer
; 21(1): 1094, 2021 Oct 11.
Article
in English
| MEDLINE | ID: mdl-34635061
8.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
J Natl Compr Canc Netw
; 19(3): 254-266, 2021 03 02.
Article
in English
| MEDLINE | ID: mdl-33668021
9.
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression.
Clin Lung Cancer
; 25(1): 50-60.e6, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37813713
10.
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 119(1): 56-65, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-37652303
11.
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation.
Clin Lung Cancer
; 25(3): e161-e171, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38195320
12.
Visualization of the bone marrow biopsy needle track.
Am J Hematol
; 93(3): E60-E61, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29168229
13.
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System.
Clin Lung Cancer
; 24(5): 474-482, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37076396
14.
Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 7: e2300191, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37499192
15.
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer.
Clin Transl Radiat Oncol
; 39: 100581, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36691564
16.
Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed.
Clin Lung Cancer
; 23(4): e310-e316, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35393247
17.
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study.
JTO Clin Res Rep
; 3(4): 100301, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35392653
18.
Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy.
Clin Lung Cancer
; 22(1): 58-66.e3, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33279417
19.
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy.
JCO Precis Oncol
; 52021.
Article
in English
| MEDLINE | ID: mdl-34095713
20.
Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical Practice.
Cancers (Basel)
; 12(5)2020 May 04.
Article
in English
| MEDLINE | ID: mdl-32375398